BioCentury
ARTICLE | Financial News

Oxagen nets 30 million

December 21, 2000 8:00 AM UTC

Oxagen (Abingdon, U.K.), which is discovering disease-related genes, netted 30 million ($44.2 million) in private financing through Schroder Ventures; Abingworth; 3i Bioscience Investment Trust and 3i...